Table 2.
Primer | Sequence |
---|---|
ARG1 |
Forward, 5′- GTGGAAACTTGCATGGACAAC -3′ Reverse, 5′- AATCCTGGCACATCGGGAATC -3′ |
IDO |
Forward, 5′- GCCAGCTTCGAGAAAGAGTTG -3′ Reverse, 5′- ATCCCAGAACTAGACGTGCAA -3′ |
IL1B |
Forward, 5′- ATGATGGCTTATTACAGTGGCAA -3′ Reverse, 5′- GTCGGAGATTCGTAGCTGGA -3′ |
IL6 |
Forward, 5′- ACTCACCTCTTCAGAACGAATTG -3’ Reverse, 5′- CCATCTTTGGAAGGTTCAGGTTG -3′ |
CCR2 |
Forward, 5′- CCACATCTCGTTCTCGGTTTATC -3′ Reverse, 5′- CAGGGAGCACCGTAATCATAATC-3′ |
CD274 |
Forward, 5′- TGGCATTTGCTGAACGCATTT -3′ Reverse, 5′- TGCAGCCAGGTCTAATTGTTTT -3′ |
LGALS9 |
Forward, 5′- GGGCGCAGACAAAAACCTC -3′ Reverse, 5′- GGAGTAGAGAACATCTGTCCAGG -3′ |
β-actin |
Forward, 5′- AGAGCTACGAGCTGCCTGAC -3′ Reverse, 5′- AGCACTGTGTTGGCGTACAG -3′ |